سعر نيتروفيونال 220مجم/5مل 60مل معلق 2022

Nitrofurinal 220 mg/5 ml nifuroxazide oral suspension (Pharopharma, Egypt), 60 ml bottle; intestinal anti-infective for bacterial diarrhoea.

• Acute and chronic diarrhoea of bacterial originPopulation: Infants from 1 month, children and adultsRejestr Produktów Leczniczych (Poland)
• Other diarrhoeal conditions, e.g. acute food poisoningPopulation: Infants from 1 month, children and adultsRejestr Produktów Leczniczych (Poland)

• Allergic reactions (rash, urticaria, angioedema, anaphylactic shock), frequency not known; one case of granulocytopenia; abdominal pain, nausea and worsening diarrhoea in hypersensitive individuals; rare skin rash.International label, equivalent formulation · Rejestr Produktów Leczniczych (Poland)

• Hypersensitivity to nifuroxazide, nitrofuran derivatives or excipients; premature infants and neonates under 1 month of age.International label, equivalent formulation · Rejestr Produktów Leczniczych (Poland)

• Do not use longer than 7 days; give a systemic antibiotic for severe invasive diarrhoea (only 10-20% absorbed); stop immediately on hypersensitivity; maintain rehydration and appropriate diet; avoid alcohol; contains sucrose and methyl parahydroxybenzoate (possible delayed allergy).International label, equivalent formulation · Rejestr Produktów Leczniczych (Poland)

• AlcoholMay cause disulfiram-like reactions.Rejestr Produktów Leczniczych (Poland)
• Other oral medicinesDo not take other oral medicines at the same time because of the strong adsorptive properties of nifuroxazide.Rejestr Produktów Leczniczych (Poland)
• Drugs causing disulfiram-like reactions; CNS depressantsConcomitant use is not recommended (French capsule SmPC).ANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Limited data in pregnant women and insufficient animal studies; possible mutagenic potential; not recommended in pregnancy or in women of child-bearing potential not using effective contraception.International label, equivalent formulation · Rejestr Produktów Leczniczych (Poland)
• Unknown whether excreted in milk; not recommended during breastfeeding because of lack of clinical experience.International label, equivalent formulation · Rejestr Produktów Leczniczych (Poland)
• French capsule SmPC: breastfeeding remains possible during a short treatment.General active-ingredient information · ANSM (Agence nationale de sécurité du médicament et des produits de santé)

• Nifuroxazide: 5-nitrofuran derivative with local antibacterial action in the intestinal lumen against some Gram-positive (Staphylococcus) and Gram-negative Enterobacteriaceae (Polish SmPC 5.1); absorption is very low with an intact intestinal mucosa (French SmPC 5.2).